Home/Compounds/Pharmaceutical Intermediate/5-(((2-aminoethyl)thio)methyl)-N,N-dimethyl-2-furanmethanamine
C10H18N2OS
214.33 g/mol
Pharmaceutical IntermediateDanger
5-[[(2-aminoethyl)thio]methyl]-N,N-dimethyl-2-furanmethanamine
CAS66356-53-4EC266-330-4
Category
Pharmaceutical Intermediate
Compound Class
Amine
Primary Use
Pharmaceutical Intermediate
This compound is an intermediate used in the synthesis of ranitidine. It may cause contact dermatitis upon exposure.
Intermediate in ranitidine synthesis
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 66356-53-4
Related Compounds
ReferenceSame Category
Methyl 6-chloro-2-pyridinecarboxylate
CAS6636-55-1
pharmaceutical intermediate
ReferenceSame Category
N,O-Dimethylhydroxylamine hydrochloride
CAS6638-79-5
pharmaceutical intermediate
ReferenceSame Category
Sodium pamoate
CAS6640-22-8
pharmaceutical intermediate
ReferenceSame Category
Tert-Butyl 3-ethynylpiperidine-1-carboxylate
CAS664362-16-7
pharmaceutical intermediate
Safety Reference
Danger
H317May cause an allergic skin reaction
H334May cause allergy or asthma symptoms or breathing difficulties if inhaled
H335May cause respiratory irritation
Identifiers
IUPAC Name
2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethanamine
InChIKey
JFGCGQJHMUYGLU-UHFFFAOYSA-N
SMILES
CN(C)CC1=CC=C(O1)CSCCN
Synonyms (31)
- 5-ADFM
- Ranitidine EP Impurity B
- Ranitidine EP Impurity B; USP Ranitidine Related Compound A
- USP Ranitidine diamine; 2-[[[5-[(Dimethylamino)methyl]-furan-2-yl]methyl]sulfanyl]ethanamine
- N- Hydro Ranitidine
- Ranitidine Impurity B